Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
Intradermal vaccination with naked DNA, TTFC-E7SH, encoding the fusion protein domain1 of tetanus toxin fragment C and the shuffled version of the Human papilloma virus (HPV) E7 oncoprotein for the induction of E7 specific T cell immunity in stage IV squamous cell cancer patients

Proposed period of release:
09/04/2013 to 09/04/2023

Name of the Institute(s) or Company(ies)
Stichting Het Nederlands Kanker Instituut, Plesmanlaan 121
1066 CX Amsterdam
PO Box 90203
1006 BE Amsterdam;

3. Is the same GMO release planned elsewhere in the Community?
Not known

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
Other: no taxonomic classification.

Identity of the GMO:
The medicinal product is not a GMO per se. It is an investigational gene therapy medicinal product consisting of a purified plasmid DNA (pDNA) drug substance.
The plasmid DNA does not have a taxonomic classification.

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
Plasmid TTFC-E7SH-----

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known